Bouchey Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
1,183
+18
+2% +$18.4K 0.09% 49
2026
Q1
$1.11M Buy
1,165
+42
+4% +$42.6K 0.08% 53
2025
Q4
$1.21M Buy
1,123
+34
+3% +$32.5K 0.09% 49
2025
Q3
$831K Sell
1,089
-3
-0.3% -$2.23K 0.06% 58
2025
Q2
$851K Buy
1,092
+1
+0.1% +$777 0.07% 56
2025
Q1
$901K Sell
1,091
-16
-1% -$13.3K 0.08% 50
2024
Q4
$855K Sell
1,107
-34
-3% -$28.2K 0.07% 49
2024
Q3
$1.01M Sell
1,141
-2
-0.2% -$1.8K 0.09% 50
2024
Q2
$1.03M Sell
1,143
-55
-5% -$44K 0.1% 45
2024
Q1
$932K Buy
1,198
+45
+4% +$32K 0.09% 48
2023
Q4
$672K Hold
1,153
0.07% 53
2023
Q3
$620K Buy
+1,153
New +$594K 0.08% 55

Other funds holding LLY

Bouchey Financial Group's LLY Position: Q2 2026 in Review

Bouchey Financial Group increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $18.4K and bringing the position to 1,183 shares worth $1.42M. The position accounts for 0.09% of the portfolio, ranked #49.

Bouchey Financial Group first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bouchey Financial Group held 1,183 shares of Eli Lilly worth $1.42M as of Q2 2026.
  • Bouchey Financial Group bought 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 0.09% of Bouchey Financial Group's portfolio in Q2 2026, its #49 holding.
  • Bouchey Financial Group first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bouchey Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.